BCC Research Blog | Industry Analysis and Business Consulting

A Deep Dive into the Next Generation Sequencing Market Landscape

Written by Adarsh Rawat | Dec 7, 2023 2:00:00 PM

In the ever-evolving landscape of genomics and biotechnology, Next Generation Sequencing (NGS) has emerged as a transformative force. The NGS market has witnessed rapid growth in recent years, unlocking new possibilities in fields like healthcare, agriculture, and personalized medicine. This blog will explore the current state of the Next Generation Sequencing Market, shedding light on trends, applications, and the impact it has had on various industries.

The Basics of Next Generation Sequencing

Before we delve into the market dynamics, let's understand the basics of NGS. Next Generation Sequencing, also known as high-throughput sequencing, is a revolutionary technology that enables the rapid and cost-effective sequencing of DNA and RNA. It has replaced traditional Sanger sequencing and has brought genomics to the forefront of research and diagnostics.

Next Generation Sequencing Market Size and Growth

The NGS market has seen impressive growth over the past decade. According to BCC Research, The global Next-Generation Sequencing (NGS) market for drug development is projected to achieve a value of $2.9 billion by 2028, experiencing a substantial compound annual growth rate (CAGR) of 17.7% from the baseline of $1.3 billion in 2023 during the forecast period spanning from 2023 to 2028.

Key Market Trends

  1. Clinical Applications: NGS is increasingly being adopted in clinical settings. It plays a crucial role in diagnosing genetic disorders, monitoring cancer progression, and providing personalized treatment options.
  2. Agrigenomics: Agriculture is benefiting from NGS as well. It is used to improve crop yields, develop disease-resistant plants, and enhance breeding programs.
  3. Pharmaceutical Research: In drug discovery and development, NGS is accelerating the identification of potential drug targets and understanding disease mechanisms, leading to more efficient drug development processes.
  4. Direct-to-Consumer Testing: The rise of direct-to-consumer genetic testing services, such as 23andMe and AncestryDNA, has created a consumer market for NGS, making genetic information accessible to the general public.
  5. Technological Advancements: The NGS market is driven by ongoing technological advancements. Innovations in sequencing platforms, data analysis, and automation are making NGS more efficient and cost-effective.